AEON (AEON Biopharma, Inc.) Stock Analysis - AI Report

AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of May 21, 2026, AEON trades at $0.86 with a market cap of $22.49M and a P/E ratio of -0.22. AEON moved +0.91% today. Year to date, AEON is -23.64%; over the trailing twelve months it is +69.63%. Its 52-week range spans $0.38 to $115.57. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on AEON?

Rallies AI research for AEON combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

AEON Key Metrics

Key financial metrics for AEON
MetricValue
Price$0.86
Market Cap$22.49M
P/E Ratio-0.22
EPS$-3.95
Dividend Yield0.00%
52-Week High$115.57
52-Week Low$0.38
Volume553
Avg Volume0
Revenue (TTM)$0
Net Income$-39.22M
Gross Margin0.00%

Latest AEON News

Recent AEON Insider Trades

  • FISCHER JOST bought 60.00K (~$29.25K) on May 21, 2025.
  • FISCHER JOST bought 60.00K (~$30.36K) on May 20, 2025.
  • FISCHER JOST bought 50.00K (~$24.94K) on May 19, 2025.

AEON Analyst Consensus

AEON analyst coverage data. Average price target: $0.00.

Common questions about AEON

What is the AI research view on AEON?
Rallies AI research for AEON combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for AEON?
Rallies AI research for AEON combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is AEON research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEON. It does not provide personalized investment advice.
AEON

AEON